We then performed a paired comparison of CSF samples from SOD1‐ALS patients at baseline and with 3 months of tofersen, revealing 23 and 6 proteins being significantly down‐ or upregulated, respectively (Fig. S9). The gene discussed is SOD1; the disease is amyotrophic lateral sclerosis.